AMIT SHAH

Biotech Venture Capital Investor, S.R. One Ltd

Amit is a member of the investment team at SR One, a transatlantic life sciences venture capital firm, based in the London office. Prior to joining SR One in 2017, Amit worked in various roles at GlaxoSmithKline including late phase clinical development, global medical affairs, and early pipeline commercial strategy. He is a board certified (equiv.) plastic surgeon, specialised in microsurgical cancer reconstruction. Amit is a board member at Gladius Pharma and holds board observer position at Hotspot Therapeutics, IlluminOss, River 2 Renal Corp. and River 3 Renal Corp. In addition, since 2020, Amit has sat on the venture capital panel for the BioInnovation Institute, Novo Nordisk’s international life sciences incubator. Amit received his BA in Medical Sciences, MA in Neuroscience and MD from the University of Cambridge. Amit Shah, MD.